MEDICAMEN BIOTECH LTD. - Board Meeting Outcome for Outcome Of Board Meeting

In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2024, were approved by the Board of Directors of the Company at its meeting held today at 2:00 P.M. and concluded at 03:00 P.M